Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-11-21FDA Approved: CELEBREX — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Celebrex (celecoxib) filed by Viatris Specialty LLC. The approval covers changes requested i…
-
FDA approval · 2024-11-21FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Nephron Pharmaceuticals Corporation)
FDA approved a supplemental application for Ketorolac tromethamine filed by Nephron Pharmaceuticals Corporation under an ANDA.
-
FDA approval · 2024-11-21FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for Ketorolac Tromethamine by Alembic Pharmaceuticals Inc., indicating approval of an update to an e…
-
FDA approval · 2024-10-31FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals’ generic oxycodone/acetaminophen product.
-
FDA approval · 2024-10-31FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for HYDROCODONE BITARTRATE AND ACETAMINOPHEN by Amneal Pharmaceuticals LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-10-31FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for a hydrocodone bitartrate and acetaminophen product from Aurolife Pharma, LLC. This action approv…
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., granting approval for the gener…
-
FDA approval · 2024-10-31FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for tapentadol hydrochloride from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2024-10-31FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for oxycodone and acetaminophen (OXYCODONE AND ACETAMINOPHEN) from Amneal Pharmaceuticals of New Yor…
-
FDA approval · 2024-10-31FDA Approved: HYDROCODONE BITARTRATE AND IBUPROFEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for the combination product hydrocodone bitartrate and ibuprofen submitted by Amneal Pharmaceuticals…
-
FDA approval · 2024-10-31FDA Approved: ACETAMINOPHEN AND CODEINE PHOSPHATE — Supplemental Application (SpecGx LLC)
The FDA approved a Supplemental Application for Acetaminophen and Codeine Phosphate from SpecGx LLC, indicating a regulatory action on this …
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Elite Laboratories, Inc.)
The FDA approved a supplemental application for methadone hydrochloride from Elite Laboratories, Inc., under an ANDA. This action updates th…
-
FDA approval · 2024-10-31FDA Approved: PENTAZOCINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for the pentazocine and naloxone combination (pentazocine hydrochloride and naloxone hydrochloride) …
-
FDA approval · 2024-10-31FDA Approved: OXYCODONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for oxycodone hydrochloride by Epic Pharma, LLC, authorizing the generic product. Oxycodone hydrochl…
-
FDA approval · 2024-10-31FDA Approved: HYDROMORPHONE HYDROCHLORIDE — Supplemental Application (Ascent Pharmaceuticals Inc)
FDA approved a supplemental application for hydromorphone hydrochloride from Ascent Pharmaceuticals Inc. The action confirms regulatory appr…
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc)
FDA approved Camber Pharmaceuticals' supplemental application for methadone hydrochloride, a generic product. This confirms regulatory clear…
-
FDA approval · 2024-10-31FDA Approved: BUPRENORPHINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for buprenorphine submitted by Teva Pharmaceuticals USA, Inc., indicating an approved update to …
-
FDA approval · 2024-10-31FDA Approved: BUTRANS — Supplemental Application (Purdue Pharma LP)
FDA approved a supplemental application for BUTRANS (buprenorphine) submitted by Purdue Pharma LP.
-
FDA approval · 2024-10-31FDA Approved: MORPHINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Actavis Pharma's morphine sulfate to market a generic morphine sulfate product. This action auth…
-
FDA approval · 2024-10-31FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Eywa Pharma Inc)
FDA approved Eywa Pharma Inc's supplemental application for hydrocodone bitartrate and acetaminophen (hydrocodone/acetaminophen) under ANDA …
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., authorizing changes under the appro…
-
FDA approval · 2024-10-31FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for hydrocodone bitartrate and acetaminophen.
-
FDA approval · 2024-10-31FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Cranbury Pharmaceuticals, LLC)
FDA approved a supplemental application for a generic Hydrocodone Bitartrate and Acetaminophen product from Cranbury Pharmaceuticals, LLC.
-
FDA approval · 2024-10-31FDA Approved: PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for pentazocine hydrochloride and naloxone hydrochloride. The approval updates …
-
FDA approval · 2024-10-31FDA Approved: ROXICODONE — Supplemental Application (SpecGx LLC)
FDA approves a supplemental application for Roxicodone (oxycodone hydrochloride) submitted by SpecGx LLC, indicating changes to the product …